Bluebird bio's GAAP loss for 2021 was $819.378 million, up 32.4% from $618.695 million the previous year. Revenues were $3.662 million. The company did not generate revenues a year earlier.
Bluebird bio's GAAP loss for 2021 was $819.378 million, up 32.4% from $618.695 million the previous year. Revenues were $3.662 million. The company did not generate revenues a year earlier. 
investor.bluebirdbio.com
English (US) 